Mycotoxins as human carcinogens-the IARC Monographs classification
Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu časopisecké články
Grantová podpora
001
World Health Organization - International
PubMed
27888487
DOI
10.1007/s12550-016-0265-7
PII: 10.1007/s12550-016-0265-7
Knihovny.cz E-zdroje
- Klíčová slova
- Aflatoxins, Carcinogenicity, Fumonisins, IARC, Mycotoxins, Ochratoxin A,
- MeSH
- aflatoxiny metabolismus MeSH
- fumonisiny metabolismus MeSH
- karcinogeny metabolismus MeSH
- lidé MeSH
- modely nemocí na zvířatech MeSH
- mutageny metabolismus MeSH
- nádory chemicky indukované epidemiologie MeSH
- ochratoxiny metabolismus MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Francie MeSH
- Názvy látek
- aflatoxiny MeSH
- fumonisiny MeSH
- karcinogeny MeSH
- mutageny MeSH
- ochratoxin A MeSH Prohlížeč
- ochratoxiny MeSH
Humans are constantly exposed to mycotoxins (e.g. aflatoxins, ochratoxins), mainly via food intake of plant and animal origin. The health risks stemming from mycotoxins may result from their toxicity, in particular their carcinogenicity. In order to prevent these risks, the International Agency for Research on Cancer (IARC) in Lyon (France)-through its IARC Monographs programme-has performed the carcinogenic hazard assessment of some mycotoxins in humans, on the basis of epidemiological data, studies of cancer in experimental animals and mechanistic studies. The present article summarizes the carcinogenic hazard assessments of those mycotoxins, especially aflatoxins (aflatoxin B1, B2, G1, G2 and M1), fumonisins (fumonisin B1 and B2) and ochratoxin A (OTA). New information regarding the genotoxicity of OTA (formation of OTA-DNA adducts), the role of OTA in oxidative stress and the identification of epigenetic factors involved in OTA carcinogenesis-should they indeed provide strong evidence that OTA carcinogenicity is mediated by a mechanism that also operates in humans-could lead to the reclassification of OTA.
Zobrazit více v PubMed
Mutat Res. 2011 Jul 14;723(1):58-64 PubMed
Mutat Res. 2001 Jul 25;494(1-2):143-50 PubMed
Chem Res Toxicol. 2005 Aug;18(8):1253-61 PubMed
Mol Nutr Food Res. 2007 Sep;51(9):1131-46 PubMed
Nat Rev Cancer. 2005 Feb;5(2):113-25 PubMed
Chem Res Toxicol. 2012 Jan 13;25(1):181-90 PubMed
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2999-3004 PubMed
Arch Toxicol. 2001 Dec;75(10):583-90 PubMed
Arch Inst Pasteur Tunis. 1994 Jan-Apr;71(1-2):21-31 PubMed
Food Chem Toxicol. 2014 Dec;74:249-54 PubMed
IARC Monogr Eval Carcinog Risks Hum. 2002;82:1-556 PubMed
Environ Health Perspect. 1974 Dec;9:1-32 PubMed
Food Addit Contam. 2005;22 Suppl 1:75-87 PubMed
J Environ Pathol Toxicol Oncol. 1990 Jan-Apr;10(1-2):11-6 PubMed
J Toxicol. 2011;2011:645361 PubMed
Toxicol Appl Pharmacol. 2014 Nov 1;280(3):543-9 PubMed
IARC Sci Publ. 1993;(124):141-8 PubMed
Toxins (Basel). 2012 Apr;4(4):267-80 PubMed
Toxicol Sci. 2009 Jul;110(1):84-94 PubMed
Chem Res Toxicol. 2007 Jul;20(7):1031-7 PubMed
Carcinogenesis. 2010 Jan;31(1):71-82 PubMed
Mol Nutr Food Res. 2008 Apr;52(4):472-82 PubMed
Cell. 2000 Jan 7;100(1):57-70 PubMed
Int J Cancer. 1998 Jul 3;77(1):70-5 PubMed
Chem Biol Interact. 2000 Jun 15;127(1):29-44 PubMed
J Toxicol Environ Health. 1986;18(1):153-7 PubMed
Cell. 2011 Mar 4;144(5):646-74 PubMed
Mutagenesis. 2007 Jan;22(1):35-42 PubMed
Exp Toxicol Pathol. 2007 Oct;59(2):85-95 PubMed
Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15524-9 PubMed
Br Med J. 1976 Mar 20;1(6011):691 PubMed
Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2010 Nov;27(11):1566-73 PubMed
Cancer Res. 2008 Sep 1;68(17):6863-72 PubMed
Braz J Med Biol Res. 2006 Dec;39(12):1563-8 PubMed
Mol Carcinog. 1998 Oct;23(2):76-85 PubMed
Chem Res Toxicol. 2004 Feb;17(2):234-42 PubMed
Toxins (Basel). 2010 Jun;2(6):1428-44 PubMed
Int J Toxicol. 2004 Jan-Feb;23(1):3-10 PubMed
Toxins (Basel). 2016 Jul 04;8(7):null PubMed
Appl Occup Environ Hyg. 2000 Oct;15(10):773-84 PubMed
IARC Monogr Eval Carcinog Risks Hum Suppl. 1987;7:1-440 PubMed
Cancer Res. 1967 Dec;27(12):2370-6 PubMed
Toxicol Sci. 2012 Jun;127(2):315-30 PubMed
Int J Food Microbiol. 2007 Oct 20;119(1-2):3-10 PubMed
Mol Nutr Food Res. 2009 Jan;53(1):154-5; author reply 156-7 PubMed
Toxins (Basel). 2015 Oct 22;7(10):4253-82 PubMed
Toxicol Sci. 2011 Aug;122(2):406-14 PubMed
Free Radic Biol Med. 2001 May 15;30(10 ):1089-98 PubMed
Int Arch Occup Environ Health. 1996;68(4):207-18 PubMed
Crit Rev Toxicol. 2004 May-Jun;34(3):211-99 PubMed
Chem Res Toxicol. 2005 Jul;18(7):1091-7 PubMed
Mutat Res. 1993 Oct;289(2):265-73 PubMed
Cancer Causes Control. 2002 Feb;13(1):91-100 PubMed
Int J Cancer. 1976 Feb 15;17(2):167-76 PubMed
Environ Mol Mutagen. 1998;32(2):155-62 PubMed
Toxins (Basel). 2010 Apr;2(4):649-64 PubMed
Clin Microbiol Rev. 2003 Jul;16(3):497-516 PubMed
Chem Res Toxicol. 2010 Jan;23(1):89-98 PubMed
Toxicology. 2012 Nov 15;301(1-3):21-32 PubMed
Food Addit Contam. 2005;22 Suppl 1:58-64 PubMed
Toxicol Sci. 2011 Mar;120 Suppl 1:S28-48 PubMed
Annu Rev Microbiol. 1980;34:235-62 PubMed
Mol Nutr Food Res. 2009 Apr;53(4):467-78 PubMed
Toxicology. 2014 Oct 3;324:116-22 PubMed
Br J Cancer. 1985 May;51(5):713-26 PubMed
Mol Nutr Food Res. 2006 May;50(6):513-8 PubMed
Nephron. 1993;64(4):621-5 PubMed
Mol Nutr Food Res. 2013 Mar;57(3):504-15 PubMed
Chem Res Toxicol. 2012 Feb 20;25(2):252-62 PubMed
Chem Res Toxicol. 2004 Sep;17(9):1289-96 PubMed
J Agric Food Chem. 2002 Feb 13;50(4):938-45 PubMed
Arh Hig Rada Toksikol. 2009 Dec;60(4):465-83 PubMed
Occurrence of mycotoxins in milk thistle: to be included in legislation or not?
Hazard characterisation for significant mycotoxins in food
Natural Occurrence of Ochratoxin A in Spices Marketed in the Czech Republic during 2019-2020
Aflatoxins: History, Significant Milestones, Recent Data on Their Toxicity and Ways to Mitigation
A Recent Overview of Producers and Important Dietary Sources of Aflatoxins
A Review on Mycotoxins and Microfungi in Spices in the Light of the Last Five Years
Occurrence of ochratoxin A in Astragalus propinquus root and its transfer to decoction